Wnt3a is a promising target in colorectal cancer
- PMID: 36719558
- DOI: 10.1007/s12032-023-01958-2
Wnt3a is a promising target in colorectal cancer
Abstract
Most colorectal cancers (CRC) are associated with activated Wnt signaling, making it the fourth most prevalent type of cancer globally. To function properly, the Wnt signaling pathway requires secreted glycoproteins known as Wnt ligands (Wnts). Humans have 19 Wnts, which suggest a complicated signaling and biological process, and we still know little about their functions in developing CRC. This review aims to describe the canonical Wnt signaling in CRC, particularly the Wnt3a expression pattern, and their association with the angiogenesis and progression of CRC. This review also sheds light on the inhibition of Wnt3a signaling in CRC. Despite some obstacles, a thorough understanding of Wnts is essential for effectively managing CRC.
Keywords: Angiogenesis; Chemoresistance; Colorectal cancer; Wnt pathway; Wnt3a.
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
References
-
- Guirguis-Blake JM, Evans CV, Perdue LA, et al. Aspirin use to prevent cardiovascular disease and colorectal cancer: an evidence update for the US preventive services task force. JAMA. 2022. https://doi.org/10.1001/jama.2022.3337 . - DOI - PubMed
-
- Liu J, Xiao Q, Xiao J, et al. Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities. Signal Transduct Target Ther. 2022;7:1–23.
-
- Neiheisel A, Kaur M, Ma N, et al. Wnt pathway modulators in cancer therapeutics: an update on completed and ongoing clinical trials. Int J Cancer. 2022. https://doi.org/10.1002/ijc.33811 . - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
